The HIV-1 envelope glycoprotein is expressed on the viral membrane as a trimeric complex, formed by three gp120 surface glycoproteins non-covalently associated with three membrane-anchored gp41 subunits. The labile nature of the association between gp120 and gp41 hinders the expression of soluble, fully cleaved, trimeric gp140 proteins for structural and immunization studies. Disruption of the primary cleavage site within gp160 allows the production of stable gp140 trimers, but cleavage-defective trimers are antigenically dissimilar from their cleaved counterparts. Soluble, stabilized, proteolytically cleaved, trimeric gp140 proteins can be generated by engineering an intermolecular disulfide bond between gp120 and gp41 (SOS), combined with a single residue change, I559P, within gp41 (SOSIP). We have found that SOSIP gp140 proteins based on the subtype A HIV-1 strain KNH1144 form particularly homogenous trimers compared to a prototypic strain (JR-FL, subtype B). We now show that the determinants of this enhanced stability are located in the N-terminal region of KNH11144 gp41 and that, when substituted into heterologous Env sequences (e.g., JR-FL and Ba-L) they have a similarly beneficial effect on trimer stability. The stabilized trimers retain the epitopes for several neutralizing antibodies (b12, 2G12, 2F5 and 4E10) and the CD4-IgG2 molecule, suggesting that the overall antigenic structure of the gp140 protein has not been adversely impaired by the trimer-stabilizing substitutions. The ability to increase the stability of gp140 trimers might be useful for neutralizing antibody-based vaccine strategies based on the use of this type of immunogen. Published by Elsevier Inc.
Introduction
The ability of human immunodeficiency virus type 1 (HIV-1) to enter its target cell and establish an infection is dependent on interactions between functional envelope glycoprotein (Env) complexes on the virus and receptors on the host cell. The HIV-1 Env complex is initially synthesized as the polyprotein precursor gp160, which undergoes oligomerization, disulfide bond formation and extensive glycosylation in the endoplasmic reticulum (Earl et al., 1991) , and is then proteolytically cleaved into the surface (gp120) and transmembrane (gp41) subunits by furin-like endo-proteases in the Golgi network (Fields et al., 1996; Hunter and Swanstrom, 1990) . The resulting Env complex is a trimer, with three gp120 proteins associated non-covalently with three gp41 subunits. During the entry process, gp120 interacts with the CD4 receptor, which triggers conformational changes that facilitate gp120 binding to a coreceptor, CCR5 or CXCR4 (Berger et al., 1999; Rizzuto et al., 1998) . These interactions promote extensive conformational changes in the gp41 subunit that drive the insertion of the hydrophobic gp41 N-terminal region (fusion peptide) into the host cell membrane. Subsequently, formation of the sixhelix bundle configuration of the three gp41 ectodomains forces the juxtaposition of the viral and cell membranes, promoting their fusion (Doms and Moore, 2000; Jones et al., 1998; Melikyan et al., 2000; Moore and Doms, 2003; Sattentau and Moore, 1991; Sullivan et al., 1998; Wu et al., 1996; Zhang et al., 1999) . Virology 360 (2007) 199 -208 www.elsevier.com/locate/yviro
The trimeric nature of the Env complex has been confirmed by various lines of evidence Center et al., 2001 Center et al., , 2002 Chan et al., 1997; Chan and Kim, 1998; Lu et al., 1995; Zhu et al., 2003) , most recently by cryo-electron microscopy (Zanetti et al., 2006; Zhu et al., 2006) . The trimer is held together by labile, non-covalent inter-subunit interactions. The weak interactions between gp120 and gp41, and between individual gp41 subunits, are probably necessary for the conformational changes that drive membrane fusion, but they complicate the generation of soluble forms of Env trimers that are suitable for vaccine research and structural studies. To obtain soluble Env trimers, the transmembrane (TM) region and the cytoplasmic tail (CT) are routinely deleted from gp41 to create gp140 proteins that contain gp120 and the gp41 ectodomain (gp41 ECTO ). There are different ways to stabilize the non-covalent inter-subunit interactions: some groups mutate the cleavage site within gp140 to make uncleaved oligomers (Chakrabarti et al., 2002; Srivastava et al., 2002; Yang et al., 2000 Yang et al., , 2002 Zhang et al., 2001) ; our approach has been to engineer an inter-subunit disulfide bond (SOS) between gp120 and gp41, and an isoleucine to proline substitution at position 559 (I559P) in the N-terminal heptad region of gp41 ectodomain (SOSIP) to promote gp41-gp41 association. We recently characterized a soluble, cleaved SOSIP gp140 protein from the subtype A virus KNH1144 (Beddows et al., 2006) . Compared to other SOSIP gp140s we have studied, particularly from JR-FL, the KNH1144 protein formed more homogenous trimers; the fewer monomers, dimers, tetramers and aggregates present suggest that the trimer form was unusually stable (Beddows et al., 2006) . Here, we have studied the molecular determinants of enhanced trimer stability. We find that they lie within the N-terminal region of gp41 ECTO , an area with a well-documented role in gp41-gp41 interactions Shugars et al., 1996) . Specifically, we show that five amino acid changes based on the KNH1144 sequence have a trimer-stabilizing effect on heterologous gp140 proteins. The introduction of these changes did not impair the exposure of various neutralizing antibody epitopes on the resulting gp140 proteins, suggesting that the overall antigenic structure of the trimer is not adversely affected. 
Results
Specific amino acids in the N-terminal region of gp41 ECTO contribute to enhanced oligomerization of cleaved gp140 from KNH1144
We recently reported that cleaved, SOSIP gp140 proteins from the subtype A strain KNH1144 form unusually stable and homogenous trimers compared to JR-FL SOSIP gp140, which is expressed as both dimers and trimers . The SOS gp140 protein from KNH1144 is also more stable than the corresponding JR-FL construct, the latter being expressed as a mixture of trimers, dimers and, predominantly, monomers (Beddows et al., 2006; Binley et al., 2000) . On purification, JR-FL SOS gp140 yields mostly monomeric gp140 proteins as a result of the instability of the gp41-gp41 interactions . We therefore sought to determine why the KNH1144 gp140 was better able to form stable trimers. The N-terminal region of gp41, particularly around the Heptad Repeat 1 (HR1) region, plays a role in oligomerization of gp140 proteins (Center et al., , 2004 Poumbourios et al., 1997) . When the N-terminal regions of gp41 from KNH144 and JR-FL were aligned, five amino acids were seen to differ, as follows (KNH1144 vs. JR-FL): I535M, Q543L, S553N, K567Q and R588G (Fig. 1) . To determine, which, if any, of these five differences contributed to the enhanced stability of KNH1144 trimers, we substituted each residue in KNH11144 SOSIP gp140 with the corresponding one from JR-FL, then expressed the mutant Env proteins and studied them on BN-PAGE gels. The wild-type forms of KNH1144 SOS and SOSIP gp140 proteins were also analyzed, to allow a comparison with the trimer-stabilizing effect of the I559P substitution in the SOSIP version ( Fig. 2A) . In general, the amino acid substitutions described below had similar effects whether they were made in the SOS or the SOSIP gp140 background, so only a subset of the results is depicted.
The S553N and R588G changes had little or no effect on trimer formation by KNH1144 SOSIP gp140 (Fig. 2B , lanes 3 and 5), whereas the I535M substitution enhanced trimer formation (Fig. 2B , lane 1), an observation we confirmed in a larger-scale expression and purification study (data not shown). In contrast, substitutions of glutamine and lysine at positions 543 and 567 (Q543L and K567Q) destabilized the KNH1144 SOSIP gp140 trimers (Fig. 2B , lanes 2 and 4). When all five amino acids were substituted in the KNH1144 SOS and SOSIP gp140 templates, the destabilizing effect on trimer formation was pronounced. The extent of the increase in monomer formation, compared to wild-type, was estimated to be ∼ 45% and ∼60% for the KNH1144 SOSIP and SOS gp140 mutants, respectively (Fig. 2C , lane 1, SOSIP; lane 2, SOS; compare with Fig. 2A ). Hence, we conclude that the five amino acid differences between the N-terminal regions of KNH1144 and JR-FL gp41 do influence the stability of cleaved gp140 trimers.
Substitution of five amino acids from the N-terminal region of KNH1144 gp41 ECTO promotes JR-FL gp140 trimer formation
We used both the SOS and SOSIP versions of JR-FL gp140 as templates on which to explore the effects of the five amino acid differences in the KNH114 gp41 ectodomain, to ensure we took into account the additional, possibly complicating, influence of the I559P change. In the first construct, a chimera, the JR-FL gp120 subunit was combined with the KNH1144 gp41 ectodomain (JR-FLgp120-1144gp41 ECTO); the second construct was a mutant JR-FL SOS gp140 in which the five varying amino acids (positions 535, 543, 553, 567 and 588) were substituted by the corresponding residues from KNH1144 (JR-FL gp41 NT 1-5); the third was another chimera in which the C-terminal region of gp41 ECTO from JR-FL was replaced by the corresponding segment of KNH1144 gp41 (JR-FL gp120-1144 gp41 CT) (Fig. 3A) .
The various chimeric and mutant envelope glycoproteins were expressed in HEK293T cells and analyzed on BN-PAGE gels (Fig. 3B ). JR-FL SOS gp140 was predominantly monomeric whereas the SOSIP gp140 formed dimers and trimers ( Fig. 3B , lanes 1 and 2). The insertion of gp41 ECTO from KNH1144 into the JR-FL SOS gp140 template stabilized the trimeric form, with a reduction in the amount of monomers present (Fig. 3B, lane 3) . The same change, but made in the JR-FL SOSIP gp140 context, had a lesser effect (Fig. 3B , compare lanes 2 and 4). Swapping the C-terminal region of gp41 ECTO in either SOS or SOSIP JR-FL gp140 had no visible effect on oligomerization (Fig. 3B , compare lane 1 to lane 5 and lane 2 to lane 6). In contrast, oligomer formation by JR-FL SOS or SOSIP gp140 was increased by the substitution of the five varying amino acids in gp41 ECTO with the corresponding residues from KNH1144 (M535I, L543Q, N553S, Q567K and G588R) (Fig. 3B , compare lane 7 to lane 1 and lane 8 to lane 2). Taken together, these results confirm that the trimer-promoting determinants of KNH1144 are located in the N-terminal region Fig. 4. (A) The wild-type JR-FL SOS gp140 and (B) the JR-FL gp41 NT 1-5 SOS gp140 mutant were analyzed by size-exclusion chromatography followed by BN-PAGE and Western blotting with MAb CA13. The mutant protein is predominantly trimeric, the wild-type protein mostly monomeric. of gp41. Moreover, the greater stability of KNH1144 gp140 trimers can be conferred upon a heterologous gp140, JR-FL, by altering the specific residues that differ between the two proteins. Further studies showed that all five changes were necessary for creating an optimally stable and homogenous JR-FL gp140 trimer; various combinations of the five changes had negligible or partial effects (data not shown).
To ascertain whether the chimeric/mutant proteins were fully cleaved, we analyzed the JR-FLgp120-KNH1144gp41(ECTO) SOS gp140 chimera and the JR-FL gp41 NT 1-5 SOS gp140 mutant, using Sodium-dodecyl sulfate polyacrylamide electrophoresis (SDS-PAGE) (Fig. 3C) . Under denaturing conditions, both gp140 proteins were resolved as monomers (lanes 1 and 3) . When DTT was added to reduce the SOS disulfide bond, release of the gp120 subunit was complete (lanes 2 and 4), along with gp41 ECTO (which is not detectable by the b13 MAb used for blotting). Hence aberrantly linked, uncleaved products do not contribute to the enhanced oligomerization of JR-FL gp140 conferred by substitution of the residues from the KNH1144 gp41 N-terminal region. The stabilized, mutant proteins are fully cleaved.
To further assess the formation and stability of JR-FL gp41 NT 1-5 SOS gp140 trimers, this protein and JR-FL SOS gp140 were purified using lectin-affinity and size-exclusion chromatography (SEC) techniques. The SEC-fractionated aliquots were then resolved by BN-PAGE (Fig. 4) . The JR-FL SOS gp140 protein was predominantly a monomer ( Fig. 4A ) whereas a much greater proportion of the Env species present in JR-FL gp41 NT 1-5 SOS migrated as well-resolved trimers ( Fig. 4B ; compare lanes 11-16 with the corresponding lanes in Fig. 4A) . A densitometric analysis of the resolved gp140 trimer, dimer and monomer fractions on BN-PAGE was combined with BCA quantification of the pooled SEC fractions (trimer, dimer and monomer), to estimate the change in each gp140 species. Compared to the wild-type JR-FL SOS gp140 protein, trimer formation by JR-FL gp41 NT 1-5 SOS gp140 was increased by ∼ 20% and dimer formation by ∼ 10%, whereas the monomer content was reduced by ∼ 50%.
Antigenic properties of the wild-type JR-FL SOS and stabilized JR-FL gp41 NT 1-5 SOS mutant gp140s
To determine whether the antigenicity of the mutant JR-FL gp140 had been altered by the introduction of the trimerstabilizing substitutions, we used SPR methods to study its binding of various antibodies, in comparison to the wild-type gp140. In these studies, biotinylated Protein G was immobilized onto a Streptavidin (SA)-coated chip, which was then used to capture various agents via their Fc regions. The CD4-IgG2 protein (used as a surrogate for CD4) and the following MAbs were all studied: b12 (neutralizing, anti-CD4BS), 2G12 (neutralizing, high-mannose epitope on the 'silent face'), 2F5, 4E10 (both neutralizing, anti-gp41), PA-1 (non-neutralizing, anti-V3), b6 (non-neutralizing, anti-CD4BS) and 17b (nonneutralizing, CD4-induced epitope). Equal molar amounts of purified wild-type and mutant gp140 trimers (> 90% purity) were then injected at 10 μl/min, to react with the immobilized MAbs.
Both the wild-type SOS gp140 and the mutant gp41 NT 1-5 SOS gp140 bound CD4-IgG2 similarly ( Fig. 5A and Table 1 ). Their reactivities with b12 and 2G12 were also similar, with similar response unit (RU) values at the end-ofinjection time (t = 180 s). The two neutralizing anti-gp41 MAbs, 2F5 and 4E10, also bound similarly to the two gp140 proteins (Fig. 5A and Table 1 ). In the absence of sCD4 (D1D2-CD4), neither gp140 protein bound efficiently to MAb 17b, but when D1D2-CD4 was added, the 17b epitope was induced on both proteins. The extent of the induction was greater for the stabilized trimer than for the wild-type protein (25-fold compared to 5-fold, respectively; Fig. 5A and Table  1 ). The non-neutralizing MAbs PA-1 and b6 bound less efficiently to the stabilized trimer than to its wild-type counterpart ( Fig. 5A and Table 1 ). We are presently investigating the basis for this observation in more detailed studies that use a variety of techniques.
To ensure that we were comparing the MAb binding properties of two trimer variants (wild-type and stabilized), the injected gp140 samples used in the ligand-binding assays were manually collected from the BIAcore X system and analyzed using BN-PAGE. Both gp140 proteins were substantially trimeric, even after passage through the BIAcore system (Fig. 5B) .
Substitution of four amino acids in N-terminal region of gp41 ECTO also increases the stability of SOS gp140 from HIV-1 Ba-L To test whether the trimer-stabilizing effect of the above five gp41 amino acids was a generalized phenomenon, we studied another subtype B Env protein, Ba-L. Like JR-FL, Ba-L contains Met, Leu, Asn and Gln residues at positions 535, 543, 553 and 567, respectively. However, at position 588, Ba-L contains Arg, as does KNH1144 (Fig. 1) . We therefore introduced the four non-cognate amino acids from KNH1144 into the N-terminal region of Ba-L (M535I, L543Q, N553S, Q567K) to construct a mutant Ba-L gp41 NT 1-4 SOS gp140 protein. When expressed in HEK293T cells, the wild-type Ba-L SOS gp140, like JR-FL, was a mixture of monomers, dimers and trimers (Fig. 6A, lane 1) . However, the mutant containing the above four amino acid substitutions was predominantly trimeric (Fig. 6A, lane 2) , with > 40% reduction in monomer formation. No individual substitution had as pronounced an effect as the quadruple combination (data not shown). The enhanced trimerization of the mutant Ba-L gp41 NT 1-4 SOS gp140 was not attributable to the presence of aberrantly cross-linked proteins, as shown by SDS-PAGE under reducing and nonreducing conditions (Fig. 6B) . Thus, under denaturing conditions, in the absence of the reducing agent, the mutant protein resolved as monomeric gp140; in the presence of DTT, reduction of the disulfide bond dissociated the gp140 into its constituent subunits (as in Fig. 3C , only the gp120 component is detected in this analysis).
Taken together, these results suggest that modifications of a few selected amino acids in the N-terminal region of gp41 can improve the stability of gp140 trimers and that the finding might be generalizable to diverse HIV-1 genotypes.
Discussion
Here, we have identified residues in the N-terminal region of the gp41 ectodomain that influence the stability of trimeric forms of the HIV-1 gp140 glycoprotein, particularly the trimers that most, but of course incompletely, resemble the native form of the Env complex. The residues were found by inspection of the sequence of gp41 ECTO from a subtype A SOSIP gp140 (KNH1144) that formed stable, cleaved trimers with unusual efficiency. Comparison of this sequence with that of JR-FL, a strain from which homogenous trimers are less easily made, identified five variable residues in a plausibly relevant region of gp41 ECTO that lay in and around HR1. Substitution of those five residues in KNH1144 gp140 by the corresponding ones from JR-FL destabilized the resulting gp140 trimers. Conversely, and of more relevance, formation of JR-FL gp140 trimers could be considerably improved when the variable residues from KNH1144 were introduced in place of the JR-FL residues. The same approach also improved trimer formation in the context of the Ba-L sequence, suggesting that our observation is likely to be generally relevant for making stable, cleaved gp140 trimers. Substituting naturally variable amino acids may be a less invasive way to promote trimer stabilization than previously described alternatives, such as the use of heterologous trimerization domains (Yang et al., 2000 , or the insertion of the SIV gp41 N-terminal region to make a HIV-SIV chimeric envelope glycoprotein (Center et al., 2004) .
The effect of substituting the KNH1144 gp41 residues into JR-FL and Ba-L is to reduce the heterogeneity of the oligomeric forms of SOS gp140 proteins when they are expressed as unpurified culture supernatants. Thus there was a marked decrease in the amount of monomers present, lesser but sill notable decreases in dimers, tetramers and high-molecular weight aggregates and, of most relevance, an increase in the proportion of trimers. When the stabilized JR-FL SOS gp140 protein was purified by lectin-affinity and size-exclusion chromatography, the amounts of monomers, tetramers and aggregates were reduced, whereas trimers were markedly more abundant and a small increase in the amount of dimers was also apparent. We believe that the dimers are likely to be dissociation products of trimers that arise during the purification process. This would not be too surprising, since the increase in trimerstability is presumably only relative, not absolute, compared to the wild-type protein.
Structural and biophysical studies will be necessary to determine how the amino acid substitutions in the gp41 N-terminal region increase the formation or stability of gp140 oligomers, particularly trimers. We have noted that some of the amino acids in the KNH1144 N-terminal region have longer side chains than their JR-FL counterparts (KNH1144 vs. JR-FL: Q543L, K567Q and R588G). It is also noteworthy that the S553, K567 and R588 residues in KNH1144 have greater α-helix-stabilizing propensities than the corresponding residues, N553, Q567 and G588, in JR-FL. Hence alterations in the size or the nature of the side chains may strengthen localized helixto-helix packing interactions in a way that stabilizes gp140 oligomers. As noted above, additional studies will be required to investigate this possibility, however.
We observed that both the wild-type JR-FL SOS gp140 and the stabilized JR-FL gp41 NT 1-5 SOS gp140 mutant bound similarly to neutralizing antibodies and proteins (b12, 2G12, 2F5, 4E10 and CD4-IgG2). Hence the overall antigenic structure of the stabilized gp140 trimers is not adversely influenced by the sequence changes introduced into gp41. We have also noted that the stabilized JR-FL trimers bound nonneutralizing antibodies (PA-1, b6 and 17b) to a lesser extent than the corresponding wild-type trimers. More detailed studies are required to confirm, extend and understand the structural basis of this observation, but any effect must be quite subtle in nature, given the proximity and similarity of the b6 and b12 epitopes (Pantophlet et al., 2003) . Whether stabilizing the conformation of gp140 trimers is advantageous for use of these proteins as vaccine immunogens is now under investigation.
Materials and methods

Reagents
CD4-IgG2 (PRO 542) (Allaway et al., 1995) and monoclonal antibody (MAb) PA-1 were provided by Dr. William Olson (Progenics Pharmaceuticals). Soluble D1D2-CD4 (sCD4-183, 2 domain) (Garlick et al., 1990) was obtained from the NIH AIDS Research and Reference Program. MAb CA13 (ARP3119), from Ms C. Arnold, was provided by the EU Programme EVA Centralized Facility for AIDS Reagents, NIBSC, UK (AVIP Contract Number LSHP- CT-2004-503487) . MAbs 2G12 (Calarese et al., 2003; Trkola et al., 1996) , 2F5 (Parker et al., 2001; Zwick et al., 2001 ) and 4E10 (Cardoso et al., 2005; Zwick et al., 2001) were obtained from Hermann Katinger, MAb 17b (Thali et al., 1993) from James Robinson and MAb b12 (Burton et al., 1994) from Dennis Burton. The hybridoma for the production of MAb B13 (HIV-1 gp160 Hyb, Chessie 13-39.1) (Abacioglu et al., 1994) was obtained from NIH AIDS Research and Reference Program (donated by George K. Lewis).
Plasmids and construction of chimeric and mutant env genes
Various HIV-1 env genes, cloned into the high-level mammalian expression vector pPPI4, were used for expression of soluble gp140 glycoproteins as previously described. Furin was expressed from pcDNA3.1-Furin Sanders et al., 2000) . The HIV-1 Env subtype A clone KNH1144 (accession number AF457066) (Beddows et al., 2006) and the subtype B clones JR-FL and Ba-L have been described previously . In domain-swap experiments, the JR-FL gp41 ectodomain was replaced with the corresponding region of KNH1144 gp41, using EcoRI and HindIII restriction enzymes, followed by repair of the restriction sites and verification of the sequences. Specific amino acid substitutions were made using the QuikChange® II XL sitedirected mutagenesis kit (Stratagene Inc., La Jolla, California) and the appropriate primers. The introduced mutations were verified by sequencing.
Transfection and expression of soluble gp140 envelope glycoproteins
The Human Embryonic Kidney cell line HEK293T was used for expression of the various envelope glycoproteins by transient transfection, as previously described Sanders et al., 2000 Sanders et al., , 2002 . HEK293T cells were grown in Dulbecco's modified Eagle's medium (DMEM, Gibco) supplemented with 10% fetal calf serum, penicillin, streptomycin and L-glutamine. Transient transfections were performed using Polyethylenimine (PEI) (Polysciences Inc., Warrington, PA) (Boussif et al., 1995; Kirschner et al., 2006) . For each small-scale transfection, 7 μg of env DNA and 3.5 μg of furin DNA were used. Five hours post-transfection, the 293T cells were washed and the media replaced with DMEM containing 0.05% bovine serum albumin (BSA), antibiotics (penicillin, streptomycin) and L-glutamine. Forty-eight hours post-transfection, the supernatant was collected and filtered using a 0.45 μm filter. A cocktail of protease inhibitors (Roche Diagnostics, Indianapolis, IN) was added before concentration of the supernatant by > 20-fold using the Amicon ultracentrifugal filter system (Millipore, Billerica, MA). Aliquots of concentrated supernatant were analyzed by polyacrylamide electrophoresis, or stored at − 80°C for future study.
Purification of soluble envelope glycoproteins
Supernatants (1 l) from transfected HEK293T cells were concentrated by >20-fold then processed by Lectin-affinity chromatography. The column eluate was then size-fractionated using an analytical Superose™ 6 column (GE Amersham Pharmacia, Piscataway, NJ) equilibrated with phosphate-buffered saline (PBS; 100 mM NaCl, 50 mM sodium phosphate, pH 7.0). The column was calibrated with protein standards of known molecular weights (HMW Gel Filtration Calibration Kit; Amersham Pharmacia, Piscataway, NJ). Fractions (200 μl) were collected and analyzed using Blue-native polyacrylamide electrophoresis (BN-PAGE) and SDS-PAGE. Quantification of proteins was carried out using the BCA quantification kit (Pierce) with known BSA standards.
BN-PAGE, SDS-PAGE and Western blot analysis
BN-PAGE was performed as described previously (Schulke et al., 2002) . Concentrated culture supernatants or purified protein samples were diluted with an equal volume of a loading buffer containing 100 mM 4-(N-morpholino) propane sulfonic acid (MOPS), 100 mM Tris-HCl (pH 7.7), 40% glycerol, 0.1% Coomassie blue, and loaded onto a 4-12% Bis-Tris NuPAGE gel (Invitrogen). Gel electrophoresis was performed at 100 V for 3 h using 50 mM MOPS, 50 mM Tris (pH 7.7) as electrophoresis buffer. SDS-PAGE was performed as described previously (Schulke et al., 2002) . Reduced and non-reduced samples were prepared in Laemmli sample buffer (62.5 mM Tris-HCl, pH6.8, 2% SDS, 25% glycerol, 0.01% DTT) and boiled for 5 min in the presence or absence of 50 mM dithiothreitol (DTT), respectively.
Western blot analyses were performed as described elsewhere (Schulke et al., 2002) . Following transfer, the polyvinylidene difluoride (PVDF) membrane was destained, then probed using anti-Env MAbs CA13 (ARP3119) or B13, followed by horseradish peroxidase-labeled anti-mouse immunoglobulin G (IgG) (Kirkegaard and Perry Labs), at a final concentration of 0.2 μg/ml. The bound MAbs were detected using the Western Blot Chemiluminescence Reagent Plus system (Perkin-Elmer Life Sciences, Boston, MA). Protein mixtures containing Thyroglobulin (669 kDa), Ferritin (440 kDa), Catalase (232 kDa), Lactate dehydrogenase (140 kDa) and BSA (66 kDa) (Amersham Biosciences) were used as standard markers for native gels. For denaturing electrophoresis, the MultiMark ® multi-colored standard (Invitrogen) was used.
BIAcore surface plasmon resonance (SPR)
The BIAcore X system (BIAcore Inc, Uppsala, Sweden) was used for comparison of the JR-FL WT vs. mutant gp140 env binding to various monoclonal antibodies and CD4-IgG2. All assays were performed at 25°C using HBS-EP buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% [v/v] Surfactant P20; BIAcore, Uppsala, Sweden), which was degassed for 1 h before use. The flow-rate was maintained at 10 μl/min. A BIAcore streptavidin (SA) chip was used for capturing ∼ 1000 response units (RU) of biotinylated protein G (Pierce) in both the experimental and the control flow-cells. Biotin was then used to block the uncoated streptavidin surface on both flow-cells. In the experimental cell, ∼ 1000 RU of various MAbs and CD4-IgG2 were directionally captured onto the surface-attached biotinylated Protein G via their Fc regions. Purified envelope glycoproteins (5 nM) were then injected for analysis of their ligand-binding properties. For study of the CD4-induced binding of MAbs directed to the CD4i-epitope, D1D2-CD4 (at a 6-molar excess concentration) was incubated with the envelope glycoprotein for 1 h at room temperature before injection. Following each run, the sensor surface was regenerated using two 10 μl injections of 10 mM Glycine-HCl, pH 3.0. For each analyte, association was measured for 180 s, dissociation for a further >500 s. All binding studies were performed three times (n = 3) with good reproducibility. The data were analyzed using BIAevaluation software 3.2 (BIAcore Inc). To correct for refractive index changes and instrument noise, the response data from the control flow-cell were subtracted from those obtained from the experimental flowcell. For comparison of the antigenicity profiles of the wild-type and mutant gp140 proteins, the end-of-injection RU values ± SD (n = 3) are reported.
